The n‐of‐1 trial is a particularly flexible form of randomized controlled trial that involves a single patient receiving multiple episodes of alternative therapies. Although n‐of‐1 trials are only applicable in certain treatment areas, the collection of economic data within such trials may provide unique advantages. This paper illustrates the issues around the use of economic n‐of‐1 trials with a hypothetical example, and discusses their potential for the estimation of individualized cost‐effectiveness. Copyright © 2001 John Wiley & Sons, Ltd.
|Number of pages||4|
|Publication status||Published - 22 Jan 2001|
- clinical evaluation
- patient preferences
- individualized funding